Aurobindo Pharma Q1 net profit up 4% at Rs 432 crore

By: |
Published: August 12, 2015 9:48 PM

Aurobindo Pharma today reported a 4.1 per cent increase in its net profit at Rs 432.4 crore during the first quarter ended June 30, 2015.

Aurobindo Pharma today reported a 4.1 per cent increase in its net profit at Rs 432.4 crore during the first quarter ended June 30, 2015.

The company’s net profit stood at Rs 393.4 crore in the same quarter last fiscal, it said in a statement.

The company’s net sales during the period under review stood at Rs 2,163.14 crore as against Rs 1,934.56 crore in the year-ago period.

“We are pleased to initiate the year with broad based growth across most business verticals,” company’s Managing Director N Govindarajan said in a statement.

Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the company at its meeting held today approved an interim dividend of 50 per cent, that is 50 paise per equity share of Re 1 each for 2015-16.

The interim dividend will be paid on or before September 4. The company said its formulation sales were up by 15.9 per cent to Rs 2,637.1 crore as against Rs 2,275.0 crore in the same period last yearu00b7

API sales too grew by 7.9 per cent to Rs 723 crore.

Company’s shares today closed 2.32 per cent lower at Rs 744.2 apiece on the BSE.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Finmin may review capital requirement of PSU banks after second quarter
2Industry for alternate sourcing destination as cost from China not going down: Signify Innovations
3Atmanirbhar Bharat campaign is a call to foster entrepreneurship not protectionism: Venkaiah Naidu